Portage Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PRTG and buy or sell other stocks, ETFs, and their options commission-free!About PRTG
AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists.
CEOBrittany Kaiser
CEOBrittany Kaiser
Employees—
Employees—
HeadquartersRoad Town, Tortola
HeadquartersRoad Town, Tortola
Founded1973
Founded1973
Employees—
Employees—
PRTG Key Statistics
Market cap7.60M
Market cap7.60M
Price-Earnings ratio-0.06
Price-Earnings ratio-0.06
Dividend yield—
Dividend yield—
Average volume326.42K
Average volume326.42K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$15.82
52 Week high$15.82
52 Week low$2.95
52 Week low$2.95
Stock Snapshot
As of today, Portage Biotech(PRTG) shares are valued at $6.81. The company's market cap stands at 7.6M, with a P/E ratio of -0.06.
On 2025-11-07, Portage Biotech(PRTG) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 326.42K.
The stock's 52-week range extends from a low of $2.95 to a high of $15.82.
The stock's 52-week range extends from a low of $2.95 to a high of $15.82.
People also own
Based on the portfolios of people who own PRTG. This list is generated using Robinhood data, and it’s not a recommendation.